このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Teva Pharmaceutical Industries マネジメント
マネジメント 基準チェック /24
Teva Pharmaceutical Industries'の CEO はRichard Francisで、 Jan2023年に任命され、 の在任期間は 1.42年です。 の年間総報酬は$ 25.71Mで、 6.2%給与と93.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.011%を直接所有しており、その価値は$ 2.11M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と6.9年です。
主要情報
Richard Francis
最高経営責任者
US$25.7m
報酬総額
| CEO給与比率 | 6.2% |
| CEO在任期間 | 1.4yrs |
| CEOの所有権 | 0.01% |
| 経営陣の平均在職期間 | 2.3yrs |
| 取締役会の平均在任期間 | 6.9yrs |
経営陣の近況
Recent updates
Teva Pharmaceutical: Buy This Bargain Before It's Gone
Jun 07Teva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
May 14
Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
May 09Teva Pharmaceutical Industries (NYSE:TEVA) Has A Somewhat Strained Balance Sheet
Mar 26Teva Pharmaceutical Industries: Potential Outweighs Concerns
Mar 25Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities
Feb 26A Review Of Teva's Prospects
Feb 15Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Business And Shares Still Trailing The Industry
Jan 07These 4 Measures Indicate That Teva Pharmaceutical Industries (NYSE:TEVA) Is Using Debt In A Risky Way
Dec 11Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
Dec 08Teva: Deeply Undervalued FCF Machine
Nov 20Teva: Focus On Innovation And Growth Means The Times They Are A Changing
Sep 14Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt
Sep 09The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider
Aug 26Teva Q2 Earnings: Austedo And Anda Growth Impress, But Challenges Remain
Aug 02Teva Pharmaceutical: Lacking Capabilities For Strategic Investments
Jul 20Teva Pharmaceutical: New Growth Plan Could Restore Investor Confidence
Jun 15Here's Why Teva Pharmaceutical Industries (NYSE:TEVA) Is Weighed Down By Its Debt Load
Jun 06Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment?
Feb 20What To Expect From Teva Pharmaceutical In 2023 With A New CEO
Feb 15Can Teva Pharmaceutical's Q4 results bring positive surprise?
Feb 07Teva Pharmaceutical: Stuck In A Cycle Of Hope And Disappointment
Jan 19Tamiflu supplies released from national stockpile as nationwide shortage persists
Jan 12Teva Pharmaceutical: 2023 Could Finally Be The Stock's Breakout Year
Dec 28Federal appeals court temporarily blocks generics of Vanda's Hetlioz by Teva, Apotex
Dec 16Boston jury orders Lilly to pay $176.5M to Teva in migraine drug patent suit
Nov 10Teva Pharmaceutical to pay New York $523M as part of opioid settlement
Nov 03Teva data indicates long-term benefit of Austedo for chorea associated with Huntington's
Oct 18Novartis division Sandoz reports supply issue of generic ADHD drug Adderall - Bloomberg
Oct 06Teva Pharmaceutical: Slow And Steady Road To A Higher Share Price
Sep 28Teva Pharmaceutical: Past Behind And A Promising 2023
Sep 16Teva wins European approval for biosimilar to Roche’s eye therapy Lucentis
Aug 29These 4 Measures Indicate That Teva Pharmaceutical Industries (NYSE:TEVA) Is Using Debt Extensively
Aug 05Teva flags supply constraints to ADHD drug Adderall as demand rises - Bloomberg
Aug 03Forex volatility, performance of generic drugs, opioid settlements in focus for Teva's Q2 earnings
Jul 26Teva again in the sights of New York Attorney General over alleged role in opioid crisis
Jul 11Teva names new medical chief
Jul 01Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week
Jun 20CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$478m |
| Dec 31 2023 | US$26m | US$2m | -US$559m |
報酬と市場: Richardの 総報酬 ($USD 25.71M ) は、 US市場 ($USD 13.53M ) の同規模の企業の平均を上回っています。
報酬と収益: Richardの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Richard Francis (56 yo)
1.4yrs
在職期間
US$25,706,880
報酬
Mr. Richard D. Francis serves as President and Chief Executive Officer at Teva Pharmaceutical Industries Limited since January 01, 2022 and serves as its Director. Mr. Francis served as Division Head and C...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 1.4yrs | US$25.71m | 0.011% $ 2.1m | |
| Executive VP & CFO | 4.5yrs | US$4.94m | 0.064% $ 12.4m | |
| Executive Vice President of International Markets Commercial | 2.8yrs | US$3.73m | 0.028% $ 5.4m | |
| Executive Vice President of European Commercial | 6.6yrs | US$5.16m | 0.0087% $ 1.7m | |
| Executive Vice President of Global Operations | no data | データなし | データなし | |
| Senior VP & Chief Accounting Officer | 2.6yrs | データなし | 0.00046% $ 88.9k | |
| Head of Investor Relations | no data | データなし | データなし | |
| Senior Vice President | 1.9yrs | データなし | データなし | |
| Executive VP & Chief Legal Officer | less than a year | データなし | データなし | |
| Acting Head of Global Human Resources | less than a year | データなし | 0% $ 0 | |
| Senior Vice President of Investor Relations | no data | データなし | データなし | |
| Senior VP & Chief Internal Auditor | 10.1yrs | データなし | データなし |
2.3yrs
平均在職期間
52.5yo
平均年齢
経験豊富な経営陣: TEVAの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | no data | US$25.71m | 0.011% $ 2.1m | |
| Independent Chairman of the Board | 9.4yrs | US$539.99k | 0.036% $ 7.0m | |
| Independent Director | 15.4yrs | US$340.00k | 0.18% $ 35.7m | |
| Independent Director | 8.8yrs | US$355.00k | 0.0094% $ 1.8m | |
| Independent Director | 6.9yrs | US$340.00k | 0.0084% $ 1.6m | |
| Independent Director | 8.8yrs | US$330.00k | 0.0092% $ 1.8m | |
| Independent Director | 4yrs | US$325.46k | 0.0057% $ 1.1m | |
| Independent Director | 2.7yrs | US$330.00k | 0.0043% $ 838.6k | |
| Independent Director | 6.9yrs | US$327.87k | 0.0084% $ 1.6m | |
| Independent Director | 6yrs | US$315.25k | 0.0078% $ 1.5m | |
| Independent Director | less than a year | US$176.66k | データなし |
6.9yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: TEVAの 取締役会 は 経験豊富 であると考えられます ( 6.9年の平均在任期間)。